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Abstract: Objective: To demonstrate the inhibitory function of the prodomain of tumor 
necrosis factor-α (TNF-α) converting enzyme (TACE) on TACE activity and to develop an 
approach to interfere with inflammation processes. Methods: The cDNA encoding the full-
length ectodomain (T1300) and prodomain (T591) of TACE were amplified by RT-PCR. 
The expression plasmids (pET-28a (+)-T1300 and pET-28a (+)-T591) were constructed 
and transformed into E. coli BL21. After Ni
2+-NTA resin affinity chromatography, the 
recombinant T591 protein was obtained and assayed. In order to detect its inhibiton of 
TACE activity, the mice in the LPS-induced endotoxemia model group were treated with 
the recombinant TACE prodomain protein prior to the injection of LPS. Murine peritoneal 
macrophages were isolated from mice abdominal cavity for FCM and the liver, kidney and 
lung were removed for traditionally histopathology sectioning. Results: The FCM results 
showed that the recombinant prodomain protein decreased the release of the sTNF-α, 
which mediated the accumulation of TNF-α on the surface of macrophage cells. HE 
staining proved that the recombinant protein can decrease the inflammatory response in 
internal organs of endotoxaemia mice. Conclusions: The recombinant prodomain of TACE 
has the ability to inhibit sTNF-α release, which indicates that prodomain is an effective 
antagonist of TACE and might be useful in the molecular design of anti-inflammatory 
drugs. 
Keywords: TACE; TNF-α; prodomain; inhibitor 
 
OPEN ACCESSInt. J. Mol. Sci. 2009, 10                 
 
 
5443
1. Introduction  
 
The ADAMs (a disintergrin and metalloprotease) are a family of membrane-anchored glycoproteins 
that play an important role in development, cell-cell interaction, and protein ectodomain shedding [1]. 
ADAMs are usually comprised of several different proteins modules as follows: an N-terminal signal 
sequence, prodomain, a metalloprotease domain, a disintergrin domain, a cysteine-rich domain, an 
EGF-like domain, a transmembrane domain, and a cytoplasmic tail [2,3]. A conserved cysteine residue 
in the prodomain preferentially coordinates the essential active site zinc atom of the metalloprotease 
domain, keeping ADAMs in the latent state [4,5]. Proprotein convertases (PCs) cleave the prodomain 
from the rest of the protein at a conserved RxR motif, effectively releasing the prodomain and 
switching the zinc coordination to the metalloprotease domain, thereby making it available for 
catalytic activity [6,7]. The ADAMs metalloprotease contains a catalytic site consensus sequence 
(HEXXH). However, only a subset of the ADAMs, including ADAM17, contains this motif which is 
required for potentially active metalloproteases (Figure 1) [8,9]. 
 
Figure 1. Structure of TACE. 
 
 
The tumor necrosis factor-α converting enzyme (TACE, ADAM17) was purified on the basis of its 
ability to cleave tumor necrosis factor-α [10–12]. TACE is the key protease responsible for processing 
TNF-α from the 26 KD membrane anchored precursor (mTNF-α) to the secreted, 17 KD TNF-α 
(sTNF-α) [13,14]. T-lymphocytes from TACE knock-out mice produce 90% less secreted sTNF-α than 
wild type [10]. As is known, there is large difference between the biological activities of mTNF-α and 
sTNF-α, and the overproduction of sTNF-α plays a central role in the inflammatory process. sTNF-α is 
rapidly produced by macrophages in response to infectious challenges, and augments the phagocytic 
and cytotoxic actions of macrophages, as well as triggering the synthesis and secretion of 
proinflammatory mediators, including IL-1, GM-CSF, TNF itself, and other cytokines [15,16]. In a 
word, sTNF-α was involved in various pathophysiology inflammation processes. As mentioned above, 
TACE is considered to be an important sheddase for TNF-α, so an inhibitor of TACE has the ability to 
inhibit the cleavage process of mTNF-α and then suppress the production of sTNF-α, and might be 
used to prevent sTNF-α-releated diseases [17,18].  
The prodomain of ADAM17 contains a cysteine switch sequence that presumably keeps ADAM17 
in latent form similar to other ADAMs members [19]. On the basis of this hypothesis, we presumed 
that the prodomain has the ability to maintain TACE latency. In this study, we investigated the 
inhibitory function of the prodomain on TACE catalytic activity, using a well-established LPS-induced 
endotoxemia model. With this model, we hope to develop a new approach to interfere inflammation 
processes.  Int. J. Mol. Sci. 2009, 10                 
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2. Results and Discussion  
 
2.1. Expression and Purification of TACE Prokaryotic Expression Plasmids 
 
The prokaryotic expression plasmids (pET-28a-T591 and pET-28a-T1300) were constructed 
successfully. T591 and T1300 DNA fragments contain 591bp and about 1300bp respectively, and they 
were also confirmed by sequencing.  
E. coli BL21 transformed pET-28a-T591 or pET-28a-T1300 expressed about 30 KD or 55 KD 
recombinant protein. The recombinant proteins were detected by SDS-PAGE and Western-blot as 
described in Materials and Methods (Figure 2). Circular dichroism analysis of T591 revealed the 
presence of significant secondary structure in the protein (Figure 3). The results indicated that T591 
was composed of 32.5% helix, 34.1% β-sheet, 10.2% turn, and 23.4% random structure. Software 
analysis confirmed the high similarities of the spatial structure between the recombinant protein and 
the wide-type TACE prodomain. 
 
Figure 2. SDS-PAGE and Western-blotting analysis of T591 protein and T1300 protein. 
 
1. Protein molecular mass marker; 2. non-induced T1300; 3. purified T1300; 4. western-blot of 
purified T1300; 5. non-induced T591; 6. purified T591; 7. western-blot of purified T591. 
 
The recombinant plasmids (pET-28a-T591 and pET-28a-T1300) were constructed successfully. The 
recombinant proteins (T591 protein and T1300 protein) were expressed and purified. And the purified 
productions were analyzed by SDS-PAGE and Western blot (The visualization method is coomassie 
staining). 
The circular dichroism can be used to help determine the secondary structure of the prodomain 
proteins we purified. Molecular modeling software showed that the structure of the recombinant 
protein is consistent with the predicted structure of the wild-type TACE prodomain. 
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Figure 3. Circular Dichroism analysis of T591 protein. 
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2.2. The Binding of the TACE Prodomain Protein to TACE 
 
The well coated with BSA acted as the control well. As the concentration of T1300 protein 
increased, the absorbance of the corresponding well increased also. When the concentration of T1300 
protein increased to 5 mg/L, the binding reaction was considered positive. The results demonstrated 
that the prodomain could strongly bind to the TACE catalytic domain (Table 1). 
 
Table 1. The results of ELISA showed the the recombinant pro-domain protein can be 
binded to TACE. 
Groups of coating 
antigen 
Density of coating 
（ antigen mg/L） 
Density of 
（ T1300 mg/L） 
OD450 
Pro-domain protein 
Pro-domain protein 
Pro-domain protein 
Pro-domain protein 
Pro-domain protein 
BSA 
BSA 
BSA 
BSA 
BSA 
Coating 
liquor(without 
antigen) 
20 
20 
20 
20 
20 
 
100 
50 
10 
5 
1 
100 
50 
10 
5 
1 
10 
 
0.69 
0.50 
0.42 
0.28 
0.18 
0.13 
0.16 
0.14 
0.14 
0.15 
0.08 
 
2.3. Establishment of the Endotoxemia Model  
 
The mice in the endotoxemia model group had red skin and appeared restless shortly after injection 
with LPS. Subsequently, 20 minutes after injection, five mice in the LPS group appeared chilled and 
anxious. Toxic symptoms increased after 40 minutes and included lethargy, diarrhea and cyanosis. In Int. J. Mol. Sci. 2009, 10                 
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contrast, toxic symptoms in the treated groups were significantly reduced. Mice that were injected with 
50 mg of prodomain protein were almost normal, just like those in the control group (Figure 4). HE 
staining showed the prodomain protein decreased the inflammatory response of liver, kidney and 
lunges (Figure 5). 
 
Figure 4. The mice in the endotoxemia model. 
    
A                                                                       B 
 
C 
A.  the mice in the LPS group appeared chilled and anxious. 
B.  the mice in the control group. 
C.  the mice in the treatment group (prodomain 50mg/mouse) appeared normol just like those in 
the control group. Int. J. Mol. Sci. 2009, 10                 
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Figure 5. Immunohistochemistry staining of lung, kidnap and liver (HE, original 
magnification × 200).  
         
A1                                                           A2 
         
B1                                                             B2 
       
C1                                                          C2 
(A1) liver slice of mice in endotoxic shock model group. 
(A2) Liver slice of mice in therapic group (20 mg/kg prodomain protein). 
(B1) kidnap slice of mice in endotoxic shock model group. 
(B2) kidnap slice of mice in therapic group (20 mg/kg prodomain protein). 
(C1) lung slice of mice in endotoxic shock model group. 
(C2) lung slice of mice in therapic group (20 mg/kg prodomain protein). 
 
HE staining proved the prodomain protein could decrease the inflammatory response of liver, 
kidney and lung. 
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2.4. The Prodomain Protein Mediated Accumulation of mTNF-α on Murine Peritoneal Macrophages 
 
To further confirm the inhibition of the prodomain protein on TACE, the accumulation of mTNF-α 
on the surface of murine macrophages was determined by FACS. FACS analysis indicated the 
expression of mTNF-α in the cure group was higher than that in the endotoxaemia group, and the 
difference was significant. Also, the mTNF-α expression in the cure group was clearly related to the 
concentration of the prodomain added (see Table 2). The results demonstrate that the prodomain 
protein mediated an accumulation of mTNF-α on the cell surface and led to a decrease of sTNF-α 
release from cells. 
With the concentration of the purified T1300 protein increasing, the absorbance of the 
corresponding well increased. When the concentration of T1300 was greater than 5 mg/L, the 
absorbance value of the well was more twice than that of the control well coated with BSA, and the 
reaction of corresponding well was thus considered positive. The results demonstrated that the 
prodomain could strongly bind to TACE. 
 
Table 2. The recombinant pro-domain protein mediated accumulation of mTNF-α on LPS-
stimulated macrophage cells surface. 
Groups                                                           mTNF-α expression (%) 
basic control                                                           10.12 ± 8.22 
pro-domain alone                                                    9.88 ± 6.35 
LPS-stimulation                                                      20.85 ± 10.61 
pro-domain protein (10 mg/kg) + LPS                     40.34 ± 2.31
a 
pro-domain protein (20 mg/kg) + LPS                    94.56 ± 4.11
a 
pro-domain protein (50 mg/kg) + LPS                     98.14 ± 2.43
a 
a P < 0.01 compared with LPS-stimulation group. 
 
The prodomain could inhibit the sTNF-α release from LPS-stimulated macrophage, resulting in 
accumulation of mTNF-α on the cell surface 
 
3. Experimental Section 
 
3.1. Construction of Prokaryotic Expression Plasmids of TACE 
 
The cDNA was reverse transcribed with random primers by the Reverse transcription-polymerase 
chain reaction amplification (RT-PCR) kit (TakaRa, China) using the RNA extracted as template. 
Reverse transcription conditions were 42 °C for 45 minutes and then 95 °C for five minutes. A portion  
(2  μL) of the cDNA product was used for subsequent PCR amplification. To amplify the TACE 
ecotodomain and prodomain gene, nested primers were designed and synthesized according to the 
published cDNA sequence of TACE. The first version, consisting of the catalytic, disintergrin, and 
cysteine-rich domains of TACE, referred to as T1300, was amplified with primer 1   
(5’-cacggatccttgctgacccagatcccatgaag-3’, containing the BamHI site) and primer 2   Int. J. Mol. Sci. 2009, 10                 
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(5’-ctagaattcctacatcctgtactcgtttctcac-3’, containing the EcoRI site). The second version, referred to as 
T591, encoding the prodomain of TACE, was amplified with primer 3   
(5’-gtgggatccccgcgacctccggatgac-3’, containing a BamHI site) and primer 4   
(5’-ggcgaattctcttttcactcgatgaacaag-3’, containing an EcoRI site). Subsequently, the PCR products were 
purified according to the instruction of the gel extraction kit (TakaRa, China). The purified PCR 
products (T1300, T591) were cut with BamHI and EcoRI and subsequently subcloned into the   
pET-28a(+) prokaryotic expression vector which had been previously digested with the same 
restriction enzymes to create pET-28a(+)-T1300 and pET-28a(+)-T591. Restriction enzymes and 
sequencing (Shanghai Bioasis Biotech Co. Ltd, China) were used to confirm the successful 
construction of the plasmids. 
 
3.2. Expression and Purification of TACE Ecotodomain and Prodomain 
 
E. coli BL21 (DE3) containing either pET-28a(+)-T1300 or pET-28a(+)-T591 were cultured until 
A600 reached 0.3–0.4 then induced with 1 mmol/L IPTC(Sigma, USA) at 37 °C for 6 hours. The 
proteins were obtained from the inclusion bodies and solubilized in 20 mM Tris-HCL (pH8.0) 
containing 8 M/L urea and 100 mM/L 2-ME. The solubilized proteins were refolded by a 1:100 
dilution in refolding buffer [20 mM/L Tris-HCL (pH7.6) containing 200 mM/L NaCl, 5 mM/L CaCl2, 
100 mM/L ZnCl2, 100 mM/L arginine, and 0.002% NaN3]. After incubation for 2 days at 4 °C, the 
recombinant proteins were purified using a Ni
2+-chelating resin affinity column. The purified products 
were analyzed by SDS-PAGE and Western blot. 
 
3.3. Circular Dichroism  
 
CD measurements were performed
 in a JASCO-810 spectropolarimeter. The CD spectra of the 
T591 protein was recorded at a final concentration of 0.08439 mM/L. The spectra were taken between 
190 and 350 nm at room temperature. Scans were done in triplicate. The Insight molecular modeling 
software was used to analyze the spatial structure of wide-type TACE prodomain. 
 
3.4. Binding Analysis of TACE Prodomain Protein to TACE 
 
The activity of T1300 protein can be used to approximate that of wild-type TACE enzyme [20]. So 
the binding of the prodomain (T591) protein to T1300 protein can reflect the binding of the prodomain 
to TACE. The binding analysis was performed by ELISA. 96-well polystyrene micro plates were 
coated with 100 μL 20 mg/L of the prodomain protein or BSA as a control at 4°C overnight. A series of 
dilutions of T1300 (1 mg/L, 5 mg/L, 10 mg/L, 50 mg/L, 100 mg/L) were then added to the wells 
coated with prodomain as well as to the control wells and incubated at 37 °C for 30 minutes. Each 
concentration of T1300 was tested in duplicate well. Each well was washed with rinsing buffer, 100 μL 
rabbit monoclonal anti-TACE antibody (Sigma, USA) was added, and the mixture incubated for one 
hour at 37 °C followed by washing three more times. HRP-conjugated anti-rabbit Gig (Sigma, USA) 
was then added, incubated at 37 °C for 20 minutes and washed with buffer five times. A substrate 
solution was added to bring about color development. Using a micro plate reader, the absorbance Int. J. Mol. Sci. 2009, 10                 
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(A450nm) of each well was determined. The binding activity of the prodomain protein to TACE was 
judged by the absorbance of each well. If the ratio between absorbance of the well coated with 
prodomain and that of the control well was >2, the reaction of the well was considered to be positive. 
 
3.5. LPS-Induced Endotoxaemia Model  
 
Female Kunming mice (SPF grade, four weeks old, 15 g to 20 g, from Tongji Medical College, 
China) were randomly divided into six groups of six animals. Animal care and treatment in this 
investigation complied with the ARV Statement for the use of Animals in Ophthalmic and Vision 
Research. Group A, the control group, received normal saline; Group B, the LPS-induced endotoxemia 
model group, received 0.1 mL solution that contained 10 mg D-galactosamine  and  
0.4~2 μg LPS, and the solution was injected into the vena caudalis; Group C, D and E were treatment 
groups, which were received an abdominal cavity injection with the recombinant TACE prodomain 
protein (group C: 10 mg/mouse; groupD: 20 mg/mouse; group E: 50 mg/mouse; and group F, another 
control group, received an abdominal cavity injection with prodomain alone (50 mg/mouse). 
After 30 minutes, each mouse in the treatment group was injected with the same solution as group 
B. The response of each mouse was observed, and after 6 h, the mice were sacrificed. Murine 
peritoneal macrophages were isolated from mice abdominal cavity and the liver, kidney, and lung were 
removed for traditional histopathology sectioning. 
 
3.6. Flow Cytometric Analysis of mTNF-α Level 
 
After washing twice with PBS, the murine peritoneal macrophages were incubated with anti-TNF-α 
mob (1:100 diluted in PBS, containing 1% BSA) for 1 h at 4 °C. The cells were washed twice with 
PBS, followed by incubation with FITC-conjugated goat anti-rabbit Gia (1:60 diluted in PBS, 
containing 1% BSA) for 1 h at 4 °C in the dark. Finally, the cells were washed twice with PBS and 
resuspended in 0.5 mL PBS until analysis. 
 
3.7. Statistical Analysis 
 
Statistical analysis was performed using student’s test. Values were compared between different 
groups in the experiment. P values < 0.05 were considered statistically significant. 
 
4. Conclusions 
 
Many bioactive proteins, including cytokines, growth factors and adhesion molecules, are 
synthesized as inactive transmembrane precursors that can be released into the surrounding medium 
upon proteolytic cleavage by specific endoproteinases. Among these protein, the processing and 
maturation events surrounding tumor necrosis factor-α (TNF-α) have been the most extensively 
examined to date. The enzyme responsible for TNF-a shedding was isolated in 1997 and is known as 
TNF-a-converting enzyme (TACE) [13,21]. Sequence analysis confirmed that TACE is a member of 
the ADAMs (a disintegrin and a metalloproteinase domain family), and is numbered as ADAM17 [22]. Int. J. Mol. Sci. 2009, 10                 
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TACE cleaves the 26 kD precursor of TNF-α (pro-TNF-α, mTNF-α) to
 yield the TNF-α soluble form 
(sTNF-α). Apart from TNF-α, TACE has also been implicated in the ectodomain shedding of many 
other cell-surface proteins, such as TNFR-1 and
 TNFR-2. 
TNF-α is a cytokine that mediates various inflammation-promoting biological activities. 
Overproduction of sTNF-α plays a central role in the inflammatory process [10]. To control 
inflammation and alleviate inflammatory disorders, it is important to reduce the level of sTNF-α or 
inhibit its function. Because TACE is considered an
 important sheddase for TNF-α, many attempts 
have been made to synthesize specific inhibitors to TACE that could ultimately be used to regulate 
inflammation-related pathologies [23]. None of these compounds, however, have been demonstrated to 
be TACE-specific. In this paper, we analyzed the structure of TACE to find candidates for specific 
inhibitors. The ADAM proteases are typically composed of several domains. Besides the enzymically 
active catalytic domain, an ADAM protease also has an N-terminal prodomain as well as several other 
domains at its C-terminus. The prodomain keeps the metalloprotease site of ADAMs inactive through 
a cysteine switch [24]. In vivo, cleavage of the prodomain is a prerequisite for the generation of an 
active protease. It is likely that this mechanism of maturation and activation applies to most ADAMs 
metalloproteases, including ADAM17. The cysteine switch in the TACE prodomain appears to be 
important
 for the inhibition of this enzyme, because mutation of the cysteine residue to an alanine or 
histidine leads to protease activation independent of prodomain cleavage [24]. Thus, the prodomain 
might act as a potent and specific inhibitor of the catalytic domain of the enzyme. 
In this study, we expressed and purified the prodomain protein of TACE. The results of circular 
dichroism analysis revealed a thermodynamically stable structure for the purified prodomain protein. 
Furthermore, molecular modeling software showed that the structure of the recombinant protein is 
consistent with the predicted structure of the wild-type TACE prodomain. Together with the results of 
binding experiments (Figure 4), we believe that the purified recombinant protein can be used to study 
the function of the TACE prodomain. 
Endotoxemia manifests as a severe clinical syndrome characterized by cytokine release, increased 
expression of adhesion molecules, release of reactive oxygen species and expression of acute phase 
proteins. Vascular inflammation occurs within minutes of Gram-negative bacterial infection and 
coincides with a burst of proinflammatory cytokines derived from activated monocytes and 
macrophages [25–27]. There is increasing evidence that bacteraemia and endotoxaemia stimulate the 
immune system into a self-perpetuating, generalized state of hyperactivity. Indeed, injection of LPS 
into animals reproduces the pathophysiological changes caused by live bacteria, and is considered a 
standard model for endotoxemia [28,29]. In particular, The LPS induction of sTNF-α activity appears 
to be a necessary component for LPS-induced bacterial events [30]. Human ADAM17 and its mouse 
homolog are highly similar, sharing 85% homolog and 91.9% indentity in amino acid sequences. On 
the basis of this similarity, we choose to reduce the level of sTNF-α or inhibite its function in mice by 
treatment with the human TACE prodomain prior to the injection of a sublethal dose of LPS. This 
model was used to test the ability of prodomain to control and alleviate inflammation. We found that 
endotoxic shock in mice was induced by intravenous injection of LPS resulting in severe pathological 
changes, such as haemorrhage and necrosis in lung, liver and kidney. Pretreatment of mice with TACE 
prodomain protein 30 minutes before LPS administration inhibited enzymaic cleavage of mTNF-α into 
sTNF-α, causing a marked increase in mTNF-α expression of pertioneal macrophages and decrease the Int. J. Mol. Sci. 2009, 10                 
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inflammatory response of liver, kidney and lunge. These results suggested the prodmain can inhibited
 
the proteolytic activity of ADAM17, since it could inhibit the sTNF-α production in vivo.  
ADAM17 has also been shown to be the major sheddase
 of several other proteins, including 
transforming growth factor-α, heparin-binding epidermal growth factor-like growth
 factor, fractalkine, 
p75 neurotrophin receptor, and MUC1 [31,32]. However, ADAM17 probably does not process all of 
these substrates simultaneously, and their release from membranes most likely dependent on specific 
conditions. In this paper, we established an endotoxaemia model, and only investigated the effect of 
the TACE prodomain on inhibition of the release of sTNF-α. Further study is required to determine its 
effect on other substrates.  
In summary, we drew the conclusion that the prodomain is an effective and specific antagonist of 
TACE, by means of inhibiting the catalytic activity. Inspired by the results, we deduced the TACE 
prodomain protein has the capability to serve as the effective drugs against inflammation and might be 
used to cure the TNF-α-related disease.  
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